Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.

Monoclonal antibody B72.3 binds to a glycoprotein complex with a molecular weight of 220,000 to 400,000. B72.3 reacts with approximately 50% of human mammary carcinomas and to 80% of the colon carcinomas tested but does not react appreciably with normal mammary tissue, with normal colon, or to a variety of normal adult human tissues tested using immunohistochemical techniques. B72.3 immunoglobulin G was purified and radiolabeled with 125I without significant loss in its reactivity to tumor extracts. The radiolabeled B72.3 immunoglobulin G was shown to efficiently localize human colon carcinoma xenografts in athymic mice. Tumor:tissue ratios of the localized antibody rose over the 7-day period studied, with tumor:liver, tumor:spleen, or tumor:kidney ratios of approximately 18:1 at Day 7 and a tumor:blood ratio of approximately 5:1 at Day 7. Tumor:muscle or tumor:brain ratios rose to over 100:1. The amount of radioactivity in the tumor increased for the first 2 days postinoculation of antibody and stayed constant over a 19-day period of study. Thus, there was no appreciable loss of radioiodine from the tumor over the study interval. No localization was seen in mice bearing a B72.3 antigen-negative human melanoma xenograft or with an isotype-identical control immunoglobulin G in mice bearing colon tumor xenografts. Gamma camera imaging with a pinhole collimator confirmed the ability of the radiolabeled antibody to detect the presence of colon carcinoma xenografts less than 0.5 cm in diameter over a 19-day period. The potential use of this system as a model for radioimmunotherapy will be discussed.

[1]  R. W. Baldwin,et al.  Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting , 2004, Cancer and Metastasis Reviews.

[2]  C. Mulhern,et al.  Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments. , 1983, Radiology.

[3]  J. Koziol,et al.  Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. , 1983, Cancer research.

[4]  J. Andrews,et al.  Localization of human colorectal tumor xenografts in the nude mouse with the use of radiolabeled monoclonal antibody. , 1983, Journal of the National Cancer Institute.

[5]  A. Alavi,et al.  Radioimmunodetection of human tumor xenografts by monoclonal antibodies. , 1983, Cancer research.

[6]  J. Schlom,et al.  Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas , 1983, International journal of cancer.

[7]  S. Larson,et al.  Diagnostic imaging of malignant melanoma with radiolabeled antitumor antibodies. , 1983, JAMA.

[8]  J. Schlom,et al.  Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. , 1983, Cancer research.

[9]  P. Hand,et al.  Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens. , 1983, Cancer research.

[10]  P. Hand,et al.  Monoclonal antibodies to human mammary carcinoma associated antigens and their potential uses for diagnosis, prognosis, and therapy. , 1983, Laboratory and research methods in biology and medicine.

[11]  B. Wahrén,et al.  Tumor localization of CEA‐containing human tumors in nude mice by means of monoclonal anti‐CEA antibodies , 1982, International journal of cancer.

[12]  W. Bodmer,et al.  TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS , 1982, The Lancet.

[13]  R. Mariani-Costantini,et al.  A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor‐associated antigen in human mammary carcinoma cell populations , 1982, International journal of cancer.

[14]  D. Scheinberg,et al.  Leukemic cell targeting and therapy by monoclonal antibody in a mouse model system. , 1982, Cancer research.

[15]  D. Ortendahl,et al.  Localization of mammary tumors in vivo with 131i‐labeled fab fragments of antibodies against mouse mammary epithelial (mme) antigens , 1981, Cancer.

[16]  P. Hand,et al.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Kim,et al.  Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. , 1980, Cancer research.

[18]  D. Goldenberg,et al.  Immunological considerations in the use of goat antibodies to carcinoembryonic antigen for the radioimmunodetection of cancer. , 1980, Cancer research.

[19]  E. Kim,et al.  Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin. , 1980, Science.

[20]  D. Goldenberg,et al.  Clinical studies on the radioimmunodetection of tumors containing alpha‐fetoprotein , 1980, Cancer.

[21]  D. Goldenberg,et al.  Xenogeneic antitumor antibodies in cancer radioimmunodetection. , 1980, Transplantation proceedings.

[22]  E. Kim,et al.  Axillary lymphoscintigraphy by radioimmunodetection of carcinoembryonic antigen in breast cancer. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  D. Solter,et al.  Tumor location detected with radioactively labeled monoclonal antibody and external scintigraphy. , 1979, Science.

[24]  C. Milstein,et al.  Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion , 1976, European journal of immunology.

[25]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[26]  F. Studier,et al.  Analysis of bacteriophage T7 early RNAs and proteins on slab gels. , 1973, Journal of molecular biology.

[27]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.